Hager Biosciences
Hager Biosciences is a preclinical-stage drug discovery organization. They provide pre-clinical therapeutic leads and candidates through operationally agile and effective drug discovery chemistry platforms for the pharmaceutical and biotech industries. They offer therapies for infectious diseases, metabolic disorders, neuropathic pain, substance abuse, addiction, and chronic pain.
Industries
Nr. of Employees
small (1-50)
Hager Biosciences
Bethlehem, Pennsylvania, United States, North America
Products
Pre-clinical Therapeutic Leads and Candidates
Provision of pre-clinical drug candidates and leads for pharmaceutical and biotech industries through drug discovery chemistry platforms.
FragPhore™ Platform
A drug discovery chemistry platform used to identify and develop therapeutic leads and candidates.
Medicinal Chemistry Services
Services providing medicinal chemistry expertise to support drug discovery and development projects.
Pre-clinical Therapeutic Leads and Candidates
Provision of pre-clinical drug candidates and leads for pharmaceutical and biotech industries through drug discovery chemistry platforms.
FragPhore™ Platform
A drug discovery chemistry platform used to identify and develop therapeutic leads and candidates.
Medicinal Chemistry Services
Services providing medicinal chemistry expertise to support drug discovery and development projects.